Alimera Sciences (ALIM) shares ended the last trading session 6.6% higher at $5.53. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 7.3% loss over the past four weeks.The stock rallied after the company, along with ANI Pharmaceuticals, announced the scheduled closure of their previously announced merger agreement on Sept. 16. 2024. Per the deal, Alimera is set to be acquired by ANI Pharmaceuticals.This eye drug dev ...